The Pancreatic Cancer Action Network's (PanCAN) National Board of Directors is comprised of dedicated individuals who are leaders professionally and in their communities with a broad range of ...

As members of the PanCAN Survivor Council, we serve as ambassadors of hope for anyone affected by pancreatic cancer. We recognize the importance of not going through this journey alone, and the ...

What Causes Pancreatic Cancer Pain? Both pancreatic cancer and treatment for the disease can lead to pain. Patients may feel different pain types at the same time. Patients may have upper abdominal ...

Pancreatic neuroendocrine tumors (pancreatic NETs or PNETs), also called pancreatic endocrine tumors or islet cell tumors, are tumors that form from the abnormal growth of hormone-producing cells in ...

Pancreatic cancer can be stressful and scary for patients and their loved ones. But you are not alone. Talking to someone who has experienced a similar situation can be very helpful. Anyone who has ...

Survivor, volunteer and top PurpleStride fundraiser John Walmsley spoke with PanCAN’s Paula Mukherjee about his commitment to ...

It can be difficult to keep up with all of the new discoveries and information available about pancreatic cancer. Our webinars help you stay on top of the most relevant information about pancreatic ...

PanCAN is leading large-scale, groundbreaking research initiatives that will be the catalyst for transforming the way pancreatic cancer is detected and treated. No single pancreatic cancer ...

Contact a PanCAN Patient Services Case Manager for up-to-date information about pancreatic cancer, clinical trial searches, personalized medicine and support resources. All information and services ...

Interested in Becoming a PanCAN Volunteer? Becoming a PanCAN volunteer means you're joining a passionate group committed to helping patients with pancreatic cancer and their families thrive today and ...

The Pancreatic Cancer Action Network (PanCAN) Leadership Team is a group of dedicated professionals, some of whom have been personally touched by the disease, who bring significant experience and ...

Daraxonrasib is poised to become the new standard of care for previously treated metastatic pancreatic cancer after detailed results from a Phase III clinical trial were released at the American ...